The global Polymerase Chain Reaction market size is expected to be worth around US$ 30.3 billion by 2030, according to a new report by Vision Research Reports.
The global Polymerase Chain Reaction market size was valued at US$ 28.6 billion in 2020 and is anticipated to grow at a CAGR of 1.0% during forecast period 2021 to 2030.
Growth Factors
This is driven by an increase in demand for rapid diagnostic tests and technological advancements.Key players operating in the market are focusing on introducing novel and technologically advanced devices for PCR tests. For instance, in July 2017, Bio-Rad Laboratories launched droplet digital PCR Genome Edit Detection Assays to quantify the efficiency of CRISPR-Cas9 or any other genome using the technology of Bio-Rad’s droplet digital polymerase chain reaction. This technology has gained prominence over the past few years. Furthermore, the COVID-19 outbreak has increased the growth rate of dPCR technology. Several types of research activities are being conducted for proving the accuracy of the dPCR test.
Report Highlights
The others segment dominated the market and accounted for the largest revenue share of more than 95.0% in 2020. The segment includes Real-time PCR (qPCR) and digital PCR, which dominated the overall market in 2020 due to increased adoption and wide applications in research.
The consumables and reagents segment dominated the market and accounted for the largest revenue share of more than 69.0% in 2020. This growth is attributable to a substantial demand for testing supplies for the SARS-CoV-2 pandemic and the increased availability of technologically advanced diagnostic equipment in countries with unmet clinical needs.
The technology is improving and is shifting toward easy-to-use products. For instance, MatMaCorp’s handheld PCR device MYRTA was launched in May 2021 facilitating real-time detection. A new entrant diagnostic system in the segment is the QuantStudio 5 Dx RT-PCR system, which was introduced by Thermo Fisher Scientific in March 2021 for laboratory use as well as assay development.
The medical segment dominated the market and accounted for the largest revenue share of 95.9% in 2020. The segment is anticipated to maintain its dominance over the forecast period due to its advantages in research and other applications, such as detecting and quantifying low-frequency mutations and low levels of pathogens with higher sensitivity. Moreover, increasing adoption in diagnostic centers and hospitals is propelling the growth of the segment.
Increasing adoption of PCR for food safety and detecting infection along with food-borne pathogens and toxicogenic fungi is expected to drive the market. Species identification has become increasingly vital in some applications such as meat species identification.
North America dominated the Polymerase Chain Reaction market and accounted for the largest revenue share of 37.8% in 2020. Favorable government initiatives, coupled with flexible regulatory guidelines are anticipated to propel market growth in North America. For instance, in February 2020, the Department of Health and Human Services announced the authorization of emergency use of diagnostics for detection of COVID-19. This authorization increased the number of diagnostics product launches in the region.
Key Players
Abbott
Qiagen
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
bioMérieux SA
F. Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Fluidigm Corporation
Cytiva
Stilla Technologies
Microsynth AG
JN Medsys
Danaher Corporation
Report Coverage | Details |
Market Size | US$ 30.3 billion by 2030 |
Growth Rate | CAGR of 1.0% From 2021 to 2030 |
Base Year | 2020 |
Historic Data | 2017 to 2020 |
Forecast Period | 2021 to 2030 |
Segments Covered | Type, Product, Application |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | Abbott; Qiagen; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; bioMérieux SA; F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Fluidigm Corporation; Cytiva; Stilla Technologies; Microsynth AG; JN Medsys; Danaher Corporation |
Market Segmentation
Type
Conventional PCR
Others
Product
Consumables & Reagents
Instruments
Software & Services
Application
Medical
Clinical
Pathogen Testing
Oncology Testing
Blood Screening
Others
Research
Forensic and others
Non-Medical
Food
Others
Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
The Polymerase Chain Reaction market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Polymerase Chain Reaction market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Polymerase Chain Reaction market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polymerase Chain Reaction market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Polymerase Chain Reaction market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Polymerase Chain Reaction capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Polymerase Chain Reaction by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Polymerase Chain Reaction market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Polymerase Chain Reaction market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Polymerase Chain Reaction market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Polymerase Chain Reaction industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Polymerase Chain Reaction market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Polymerase Chain Reaction market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Polymerase Chain Reaction market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Polymerase Chain Reaction market. These factors have benefited the growth of the global market for Polymerase Chain Reaction. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Polymerase Chain Reaction. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Polymerase Chain Reaction are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Polymerase Chain Reaction Market, By Type
7.1. Polymerase Chain Reaction Market, by Type, 2021-2030
7.1.1. Conventional PCR
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Others
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Polymerase Chain Reaction Market, By Application
8.1. Polymerase Chain Reaction Market, by Application, 2021-2030
8.1.1. Medical
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Non-Medical
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Polymerase Chain Reaction Market, By Product
9.1. Polymerase Chain Reaction Market, by Product, 2021-2030
9.1.1. Consumables & Reagents
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Instruments
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Software & Services
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Polymerase Chain Reaction Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.3. Market Revenue and Forecast, by Product (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.4.3. Market Revenue and Forecast, by Product (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.5.3. Market Revenue and Forecast, by Product (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.3. Market Revenue and Forecast, by Product (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.4.3. Market Revenue and Forecast, by Product (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.5.3. Market Revenue and Forecast, by Product (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.6.3. Market Revenue and Forecast, by Product (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.7.3. Market Revenue and Forecast, by Product (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.3. Market Revenue and Forecast, by Product (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.4.3. Market Revenue and Forecast, by Product (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.5.3. Market Revenue and Forecast, by Product (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.6.3. Market Revenue and Forecast, by Product (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.7.3. Market Revenue and Forecast, by Product (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.3. Market Revenue and Forecast, by Product (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.4.3. Market Revenue and Forecast, by Product (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.5.3. Market Revenue and Forecast, by Product (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.6.3. Market Revenue and Forecast, by Product (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.7.3. Market Revenue and Forecast, by Product (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.3. Market Revenue and Forecast, by Product (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.4.3. Market Revenue and Forecast, by Product (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.5.3. Market Revenue and Forecast, by Product (2016-2030)
Chapter 11. Company Profiles
11.1. Qiagen
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bio-Rad Laboratories, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. bioMérieux SA
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F. Hoffmann-La Roche Ltd
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Agilent Technologies, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Fluidigm Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Cytiva
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Stilla Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Microsynth AG
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. JN Medsys
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Danaher Corporation
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms